Journal of Cystic Fibrosis
Volume 9, Issue 2 , Pages 124-129 , March 2010

What is the best method for measuring renal function in adults and children with cystic fibrosis?

  • Natalie Soulsby

      Affiliations

    • Sansom Institute, University of South Australia, Frome Road, Adelaide SA 5001, Australia
    • Department of Pharmacy, Women's and Children's Hospital, King William Road, North Adelaide, SA 5006, Australia
    • Department of Pharmacy, Royal Adelaide Hospital, North Terrace, Adelaide SA 5000, Australia
    • Corresponding Author InformationCorresponding author. Sansom Institute, University of South Australia, Frome Road, Adelaide SA 5001, Australia. Fax: +61 8 8302.
    • ,
  • Hugh Greville

      Affiliations

    • Department of Thoracic Medicine, Royal Adelaide Hospital, North Terrace, Adelaide SA 5000, Australia
    • ,
  • Kingsley Coulthard

      Affiliations

    • Sansom Institute, University of South Australia, Frome Road, Adelaide SA 5001, Australia
    • Department of Pharmacy, Royal Adelaide Hospital, North Terrace, Adelaide SA 5000, Australia
    • ,
  • Chris Doecke

      Affiliations

    • Sansom Institute, University of South Australia, Frome Road, Adelaide SA 5001, Australia
    • Department of Pharmacy, Women's and Children's Hospital, King William Road, North Adelaide, SA 5006, Australia

Received 1 October 2009 ,Revised 4 December 2009 ,Accepted 23 December 2009.

References 

  1. Newman DJ. Cystatin C. Ann Clin Biochem. Mar 2002;39(Pt 2):89–104
  2. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function—a review. Clin Chem Lab Med. Apr 1999;37(4):389–395
  3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41
  4. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. Aug 1976;58(2):259–263
  5. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study group. Ann Intern Med. Mar 16 1999;130(6):461–470
  6. Work DF, Schwartz GJ. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. Oct 9 2009;
  7. Goates JJ, Morton KA, Whooten WW, Greenberg HE, Datz FL, Handy JE, et al. Comparison of methods for calculating glomerular filtration rate: technetium-99m-DTPA scintigraphic analysis, protein-free and whole-plasma clearance of technetium-99m-DTPA and iodine-125-iothalamate clearance. J Nucl Med. Apr 1990;31(4):424–429
  8. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. Jul 18 1996;335(3):179–188
  9. den Hollander JG Horrevorts AM, van Goor ML, Verbrugh HA Mouton JW. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. Jan 1997;41(1):95–100
  10. Ali MZ Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. May 1997;24(5):796–809
  11. Hauser W, Atkins HL, Nelson KG, Richards P. Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning. Radiology. Mar 1970;94(3):679–684
  12. Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, et al. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med. Apr 2007;24(4):443–448
  13. Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem. Jun 1999;45(6 Pt 1):882–894
  14. Bland JM Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. Jun 1999;8(2):135–160
  15. Zweig MH Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. Apr 1993;39(4):561–577
  16. Beringer PM Hidayat L, Heed A, Zheng L, Owens H, Benitez D, et al. GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. J Cyst Fibros. Jan 2009;8(1):19–25
  17. In: Renal function monitoring for IV tobramycin and colistin in patients with Cystic Fibrosis. July 22 2006;2006
  18. Inclan G, Suarez E, Calvo R, Aguirre C, Macheras P, Gazouli M, et al. Bicompartmental kinetics of tobramycin analysed with a wide range of covariates. Int J Antimicrob Agents. Oct 2005;26(4):304–311
  19. Bragonier R, Brown NM. The pharmacokinetics and toxicity of once-daily tobramycin therapy in children with cystic fibrosis. J Antimicrob Chemother. Jul 1998;42(1):103–106
  20. Aarons L, Vozeh S, Wenk M, Weiss P, Follath F. Population pharmacokinetics of tobramycin. Br J Clin Pharmacol. Sep 1989;28(3):305–314
  21. Aminimanizani A, Beringer PM Kang J, Tsang L, Jelliffe RW Shapiro BJ. Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis. J Antimicrob Chemother. Oct 2002;50(4):553–559

☆ Initial data for this study was presented at the 31st European Cystic Fibrosis Conference 11th to 14th June 2008, Prague, Czech Republic.

PII: S1569-1993(10)00002-0

doi: 10.1016/j.jcf.2009.12.002

Journal of Cystic Fibrosis
Volume 9, Issue 2 , Pages 124-129 , March 2010

Article Tools

* Image Usage & Resolution